Bernstein says UnitedHealth (UNH) remains a top pick for 2025 following the company’s Q4 report. UnitedHealth’s 2025 outlook is achievable, Medicare Advantage trends improving, the stock’s valuation is attractive, the analyst tells investors in a research note. Bernstein maintains an Outperform rating and price target of $697, implying 37% upside.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH: